French Debating Association


French Debating Association

Université Paris 2 - Panthéon Assas wins our 25th Annual tournament

banniere victoire assas.png

prEsident'S LETTER

3382_014 (1).JPG

Dear friends OF and friends IN rhetoric,

The 2018 FDA debating season beckons us and we have prepared many surprises for you. However, before embarking on the journey of next year, I would like to step a little out of tradition and speak of the season we have just finished.

From humble beginnings in 1993, the FDA has gradually progressed to become a body which organizes France’s most comprehensive national debating tournament and many other related events. Each year sees us go from strength to strength and our 2017 season’s harvest saw us reach new heights.

Our second veterans’ tournament was a huge success and our schools’ competition saw new blood take centre stage and demonstrate the prowess of a future generation of debaters.

None of this would have been possible without the energy and the devotion of our joint secretaries general (Albertine and Francesco) and I would like to use this forum to express the FDA’s extreme pride in having such hard working, industrious but especially innovative young leaders.

Now to 2018. We are happy to welcome three new members to the fold – ENSTA, IESEG and the Université de Strasbourg and we remind them that two years ago the then  rookies (Paris Ouest Nanterre) blazed a trail not only to our final but to ultimate victory!

2018 promises to be a vintage year with our proceedings reaching a finale at the Hôtel de Lassay at the Assemblée nationale on Monday mars 26 and we extend our warmest thanks to President François de Rugy for granting us this possibility.

Our veterans’ and schools’ competitions will continue to flourish and we welcome our renewed cooperation with the Franco-British Comparative Project, the University of London in Paris and Frateli, as well as the French Embassy in London.

Our aims are simple and are goals are true: debate, exchange, mutual-understanding, friendship and progress.

Yours in rhetoric,

Declan Mc Cavana,

President of the FDA